Gastrointestinal Diseases

Salix Pharmaceuticals Receives Approvable Letter from FDA for Balsalazide Tablet (Finanzen.net)

17 May 2008

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company has received an approvable letter from the U.S. Food and Drug Administration (FDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ...

With the Sun Coming Out, Get Your Vitamin D (The Morning News)

16 May 2008

Once thought of as helping only to develop strong bones, vitamin D is now believed to serve many purposes in the human body. A deficiency of the vitamin has been linked to several diseases and disorders.

Callisto Pharmaceuticals Reports Promising Interim Phase II Data for Atiprimod in Advanced Carcinoid Cancer (Business Wire via Yahoo! Finance)

16 May 2008

NEW YORK----Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and gastrointestinal disorders, announced today promising interim data from the company's ongoing open-label Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma .